NCT00345397

Brief Summary

The investigators want to know if placing a tube through the skin and into the colon to flush out the colon is safe and effective in helping spinal cord Veterans with bowel management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 28, 2006

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2014

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

May 22, 2015

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

February 1, 2019

Status Verified

January 1, 2019

Enrollment Period

7.9 years

First QC Date

June 27, 2006

Results QC Date

February 26, 2015

Last Update Submit

January 15, 2019

Conditions

Keywords

cecostomycolonoscopycolostomyconstipationendoscopy, gastrointestinalfecal incontinencepercutaneousquality of lifespinal cord injury

Outcome Measures

Primary Outcomes (1)

  • Change in Bowel QoL

    Spinal Cord Injury (SCI) -Specific, 20-Question QoL Instrument used a Visual Analog Scale (VAS) for each item. These were scored by measurement and recording 1-10 along the scale (1 being best, 10 being worst) An average of the scores for the 20-items was calculated for each subject before and after Percutaneous Endoscopic Colostomy (PEC) Tube placement. A Global SCI-QoL Score was also recorded using the same VAS. The difference between these Intake and Exit scores was used to define change in SCI-Specific Quality of Life.

    Exit data collected 1 year(+/- 6 mo) after Intake data collection / PEC placement

Study Arms (1)

Subjects Receiving PEC Tube

EXPERIMENTAL

Percutaneous Endoscopic Colostomy Tube (PEC) Placement

Device: Percutaneous endoscopic colostomy (PEC) tube

Interventions

PEC placement for antegrade enemas uses commercially available PEG tubes

Subjects Receiving PEC Tube

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SCI Veteran followed at Zablocki VAMC
  • High quality of life impact of bowels on survey
  • Ability to cooperate with data collection and follow-up requirements

You may not qualify if:

  • Unstable clinical disease
  • Untreatable co-morbidities affecting gut function
  • Colonic disease or surgery that might impact safety of Percutaneous Colostomy tube placement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clement J. Zablocki VA Medical Center, Milwaukee, WI

Milwaukee, Wisconsin, 53295-1000, United States

Location

MeSH Terms

Conditions

ConstipationFecal IncontinenceSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsRectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Limitations and Caveats

Difficulty in recruitment from a limited population reduced our intended enrollment and prolonged our study. This also reduced our statistical significance and limited our conclusions.

Results Point of Contact

Title
Mary F. Otterson, MD; Professor of Surgery
Organization
Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI

Study Officials

  • Mary F Otterson, MD

    Clement J. Zablocki VA Medical Center, Milwaukee, WI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2006

First Posted

June 28, 2006

Study Start

May 1, 2006

Primary Completion

March 31, 2014

Study Completion

December 31, 2018

Last Updated

February 1, 2019

Results First Posted

May 22, 2015

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations